
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Phase 3
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No catalyst events have been recorded for this drug yet.
1 competitor in Neovascular Age-related Macular Degeneration (nAMD)
View Full LandscapeTarget Indication
Neovascular Age-related Macular Degeneration (nAMD)
Clinical Trial
NCT05282004Last updated: 6/28/2026
No patent data available. Pre-approval drugs may not have Orange Book listings.
Rhinitis, Allergic, Seasonal
Chronic Kidney Disease
Anemia
Chronic Stable Plaque Psoriasis
Neovascular Age-related Macular Degeneration